WO2008106979A3 - Pharmaceutical compositions comprising flavonoids and xylitol - Google Patents

Pharmaceutical compositions comprising flavonoids and xylitol Download PDF

Info

Publication number
WO2008106979A3
WO2008106979A3 PCT/DK2008/050051 DK2008050051W WO2008106979A3 WO 2008106979 A3 WO2008106979 A3 WO 2008106979A3 DK 2008050051 W DK2008050051 W DK 2008050051W WO 2008106979 A3 WO2008106979 A3 WO 2008106979A3
Authority
WO
WIPO (PCT)
Prior art keywords
flavonoids
xylitol
pharmaceutical compositions
relates
compositions
Prior art date
Application number
PCT/DK2008/050051
Other languages
French (fr)
Other versions
WO2008106979A2 (en
Inventor
Kurt Berg
Original Assignee
Immupharm As
Kurt Berg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immupharm As, Kurt Berg filed Critical Immupharm As
Publication of WO2008106979A2 publication Critical patent/WO2008106979A2/en
Publication of WO2008106979A3 publication Critical patent/WO2008106979A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to use of certain sugar alcohols for reduction of viruses, in particular vira causing common cold. In one embodiment, the invention relates to pharmaceutical compositions comprising a sugar alcohol, preferably xylitol. Said compositions preferably also comprise one or more flavonoids. Said composition is preferably formulated as a chewing gum. The invention also relates to treatment of common cold using said compositions.
PCT/DK2008/050051 2007-03-02 2008-02-29 Pharmaceutical compositions comprising flavonoids and xylitol WO2008106979A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200700315 2007-03-02
DKPA200700315 2007-03-02

Publications (2)

Publication Number Publication Date
WO2008106979A2 WO2008106979A2 (en) 2008-09-12
WO2008106979A3 true WO2008106979A3 (en) 2009-05-07

Family

ID=39365437

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2008/050051 WO2008106979A2 (en) 2007-03-02 2008-02-29 Pharmaceutical compositions comprising flavonoids and xylitol

Country Status (1)

Country Link
WO (1) WO2008106979A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010048283A1 (en) 2010-10-14 2012-04-19 Schaper & Brümmer GmbH & Co. KG Buyable tablet
CN102048726A (en) * 2011-01-10 2011-05-11 华东理工大学 Application of nobiletin
US8420617B2 (en) * 2011-03-11 2013-04-16 Biocell Laboratories Multiantivirus compound, composition and method for treatment of virus diseases
CN103012348B (en) * 2012-12-19 2015-04-08 苏薇薇 6,8-substituted naringenin derivative and application thereof
KR101677855B1 (en) * 2014-08-08 2016-11-21 중앙대학교 산학협력단 Composition for preventing and treating respiratory syncytial virus (RSV) infection comprising xylitol
BR102016020391A2 (en) * 2016-09-02 2017-09-19 Abrao Saad William PHARMACEUTICAL FORMULATION BASED ON ZINC AND QUERCETIN FOR PRODUCTION OF EFFECTIVE ANTIVIRAL MEDICATION FOR DENGUE AND ZIKA
CN106667997A (en) * 2017-02-27 2017-05-17 吉林大学 EGCG with inhibitory effect on streptococcus pneumoniae pathogenicity and application
US10639294B2 (en) 2018-10-02 2020-05-05 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
US11304968B2 (en) 2018-11-16 2022-04-19 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide
AU2021281159B2 (en) * 2020-05-29 2024-09-19 Vedicinals India Private Limited A composition for management of COVID-19 and associated disorders

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003165A1 (en) * 1996-07-24 1998-01-29 Leiras Oy New use of xylitol and pharmaceutical compositions therefor
WO2002009699A2 (en) * 2000-07-28 2002-02-07 Immupharm Aps Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
WO2004037237A1 (en) * 2002-10-24 2004-05-06 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
US20060280700A1 (en) * 2005-06-08 2006-12-14 Isler Stuart L Oral hygiene system to fight the effects of aging on the mouth, gums, and teeth

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003165A1 (en) * 1996-07-24 1998-01-29 Leiras Oy New use of xylitol and pharmaceutical compositions therefor
WO2002009699A2 (en) * 2000-07-28 2002-02-07 Immupharm Aps Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
WO2004037237A1 (en) * 2002-10-24 2004-05-06 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
US20060280700A1 (en) * 2005-06-08 2006-12-14 Isler Stuart L Oral hygiene system to fight the effects of aging on the mouth, gums, and teeth

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TURNER RONALD B ET AL: "Treatment of the common cold with troxerutin", APMIS, vol. 112, no. 9, September 2004 (2004-09-01), pages 605 - 611, XP002507369, ISSN: 0903-4641 *
VERNACCHIO ET AL: "Tolerability of oral xylitol solution in young children: Implications for otitis media prophylaxis", INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 71, no. 1, 22 December 2006 (2006-12-22), pages 89 - 94, XP005811132, ISSN: 0165-5876 *

Also Published As

Publication number Publication date
WO2008106979A2 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
WO2008106979A3 (en) Pharmaceutical compositions comprising flavonoids and xylitol
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2008011363A3 (en) Quercetin-containing compositions
WO2008011364A3 (en) Quercetin-containing compositions
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2007104575A3 (en) Stable lozenge compositions providing rapid release of nicotine
WO2006102610A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109192A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109172A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2009004629A3 (en) A method for decreasing symptoms of alcohol consumption
WO2007109154A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2006110406A3 (en) Compositions comprising probiotic and sweetener components
IL195030A (en) Dpp iv inhibitor formulations
WO2007109160A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
NO20083905L (en) New pyron-indole derivatives and process for their preparation
WO2007059953A8 (en) Formulation comprising a polyphenol-containing composition and isomaltulose
WO2008001325A3 (en) Herbal compositions for the treatment of diseases of the oral cavity
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2007109182A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2008086457A3 (en) Oral care compositions comprising a hippophae extract
WO2007109201A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2006117465A3 (en) Use ot cacao polyphenols for controlling skin pigmentation
WO2008042944A3 (en) Non-irritating oral care formulations
WO2009141541A3 (en) Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08706945

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08706945

Country of ref document: EP

Kind code of ref document: A2